Companies · FTV
Fortive
AI-generated · informational only · not investment advice · verify before relying.
Latest analysis
Updated Oct 28, 2026
Fortive raises FY2026 EPS guidance to $3.10-$3.14 on fifth consecutive quarter of double-digit adjusted EPS growth and 7.2% core revenue growth in Q3.
Fortive delivered Q3 2026 core revenue growth of 7.2%, Adjusted EBITDA growth of approximately 10%, and adjusted EPS of $0.77 — up over 13% year-over-year — marking five consecutive quarters of double-digit adjusted EPS growth. The IOS segment led with 9% core growth driven by broad-based strength across Fluke, Facilities and Asset Lifecycle Solutions, and gas detection, while AHS grew 3.1% on a core basis with margin compression from deliberate growth investments and prior-year discrete cost benefit lapping. Management raised full-year 2026 adjusted EPS guidance to $3.10-$3.14 and signaled full-year core growth just north of 5%, ahead of the 3%-4% medium-term framework baseline.
Tone: bullishRevenue
$4.2B
FTV 10-K · FY 2025
Employees
10,000
Revenue growth YoY
+1.9%
EBITDA margin
30.6%
Profile
FTV 10-K Item 1 · Feb 25, 2026Fortive Corporation designs, develops, manufactures, and markets products, software, and services across two segments — Intelligent Operating Solutions and Advanced Healthcare Solutions — serving mission-critical workflows in industrial, safety, and healthcare end markets. The company operates in approximately 50 countries with a workforce of more than 10,000 professionals. In June 2025, Fortive separated its Precision Technologies segment into an independent publicly-traded company, Ralliant Corporation.
Read filing description ↓ Collapse description ↑
Fortive Corporation innovates essential technologies to keep our world safe and productive. Our strategic segments - Intelligent Operating Solutions and Advanced Healthcare Solutions - include iconic inventor brands with leading positions in their markets. Our businesses design, develop, manufacture, and market products, software, and services, building upon leading brand names, innovative technologies, and strong market positions. We are headquartered in Everett, Washington and have a workforce of more than 10,000 research and development, manufacturing, sales, distribution, service, and administrative professionals in approximately 50 countries around the world. On June 28, 2025, we separated our Precision Technologies segment business into an independent publicly-traded company named Ralliant Corporation. Our Intelligent Operating Solutions segment provides advanced instrumentation, software and services to tens of thousands of customers enabling their mission-critical workflows, including professional instruments used in applications including maintenance, repair, measurement and condition monitoring, facility and asset lifecycle software applications, and connected worker safety and compliance solutions. Our Advanced Healthcare Solutions segment supplies critical workflow solutions enabling healthcare providers to deliver exceptional patient care more efficiently, including instrument sterilization solutions, instrument tracking, biomedical test tools, radiation detection and safety monitoring, and end-to-end clinical productivity software and solutions.
Primary products
- FLUKE
- SERVICECHANNEL
- GORDIAN
- ACCRUENT
- INDUSTRIAL SCIENTIFIC
- INTELEX
Business segments
End markets
Geographies
Named customers
“Our management believes that we have a market leadership position in most of the markets we serve.” Competitive position, as stated in the filing
Revenue commentary · FY 2025
Total sales grew 1.9% in 2025 versus 2024, driven by favorable pricing of 2.2% partially offset by a volume decline of 0.6%, with core revenue growth of 1.7% on a non-GAAP basis.
The rest of FTV is for subscribers
Analysis, signals, diligence answers, M&A activity and every quote, each citing the filing it came from.